CRO SynteractHCR has appointed three new senior-level managers to strengthen its leadership team internationally. The new hires include Linda Rawlings as executive director strategic development, Pascale Goujard-Paquette as senior director of clinical operations in the EU, and Erin Parker as senior director of global medical operations.
Linda (pictured) is UK-based and has more than 25 years of experience in the CRO, pharmaceutical and medical device sectors. She has held key positions in both operations and business development.
Pascale brings to the table almost 30 years of experience in clinical research, both with pharmaceutical companies (Servier, Wyeth) and large CROs, including former roles with PRA and Quintiles where she managed hundreds of professional staff in clinical operations.
Erin has over 17 years of experience managing safety services across a diverse portfolio of complex domestic and global drug, device, industry and government-sponsored Phase I-IV studies in multiple therapeutic areas.